Diclofenac vs. Pethidine in cholecystectomy pai

Phase 3

• Conditions: Condition 1: pain. Condition 2: Cholelithiasis. Condition 3: Acute cholecystitis.; Acute pain; Cholelithiasis; Acute cholecystitis; R52.0; K81.0

• Registration Number: IRCT20140611018063N6
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

patients with detected gallstones requiring surgery
patients with biliary sludge requiring surgery

Exclusion Criteria

history of laparoscopic cholecystectomy
severe obstructive pulmonary disease
congestive heart failure (EF <20%)
acute cholecystitis
gangrenous
empyema gallbladder
intestinal fistula in the biliary tract
obesity
pregnancy
ventriculoperitoneal shunt
previous abdominal surgery
appearance of serious drug side effects
cirrhosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of prescribed drug on the severity of pain. Timepoint: measuring severity of the pain before intervention, measuring severity of the pain 24 hours after the initiation of the anti-pain drug (pethidine or diclofenac). Method of measurement: verbal rating scale of pain.